// STATE LEGISLATION TRACKER

Louisiana HB 629: HEALTH CARE: Provides with respect to informed consent for medical interventions (OR SEE FISC NOTE LF EX)

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Louisiana
Bill: HB 629
Session: 2026
Filed: 2025-04-04
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Louisiana HB629 creates a specialty motor vehicle license plate for the Krewe of Athena. Based on the title, subjects, and available bill text, it has no apparent effect on compounded peptides, prescribing, telehealth, clinician scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No peptide access changes are indicated
No changes to clinician prescribing authority
No telehealth or compounding provisions appear involved

What to Watch For

Note The bill appears limited to a specialty license plate, not health care or drug regulation.

Note Current legislative records show the bill was signed as Act 80, despite the provided OpenStates status saying prefiled.

Where the Bill Stands

Louisiana legislative records show HB629 was signed by the Governor on May 11, 2026, becoming Act 80.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws